Edwards Lifesciences Gross Profit 2010-2024 | EW
Edwards Lifesciences annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Edwards Lifesciences gross profit for the quarter ending September 30, 2024 was $1.092B, a 9.94% increase year-over-year.
- Edwards Lifesciences gross profit for the twelve months ending September 30, 2024 was $4.868B, a 14.49% increase year-over-year.
- Edwards Lifesciences annual gross profit for 2023 was $4.625B, a 7.51% increase from 2022.
- Edwards Lifesciences annual gross profit for 2022 was $4.302B, a 7.99% increase from 2021.
- Edwards Lifesciences annual gross profit for 2021 was $3.984B, a 20.51% increase from 2020.
| Edwards Lifesciences Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $4,625 |
| 2022 | $4,302 |
| 2021 | $3,984 |
| 2020 | $3,306 |
| 2019 | $3,234 |
| 2018 | $2,783 |
| 2017 | $2,560 |
| 2016 | $2,166 |
| 2015 | $1,877 |
| 2014 | $1,697 |
| 2013 | $1,529 |
| 2012 | $1,409 |
| 2011 | $1,189 |
| 2010 | $1,039 |
| 2009 | $922 |
| Edwards Lifesciences Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,092 |
| 2024-06-30 | $1,101 |
| 2024-03-31 | $1,213 |
| 2023-12-31 | $1,464 |
| 2023-09-30 | $993 |
| 2023-06-30 | $1,039 |
| 2023-03-31 | $1,130 |
| 2022-12-31 | $1,090 |
| 2022-09-30 | $1,065 |
| 2022-06-30 | $1,105 |
| 2022-03-31 | $1,042 |
| 2021-12-31 | $1,020 |
| 2021-09-30 | $999 |
| 2021-06-30 | $1,042 |
| 2021-03-31 | $923 |
| 2020-12-31 | $895 |
| 2020-09-30 | $860 |
| 2020-06-30 | $687 |
| 2020-03-31 | $864 |
| 2019-12-31 | $888 |
| 2019-09-30 | $802 |
| 2019-06-30 | $783 |
| 2019-03-31 | $761 |
| 2018-12-31 | $743 |
| 2018-09-30 | $682 |
| 2018-06-30 | $698 |
| 2018-03-31 | $661 |
| 2017-12-31 | $653 |
| 2017-09-30 | $608 |
| 2017-06-30 | $631 |
| 2017-03-31 | $668 |
| 2016-12-31 | $555 |
| 2016-09-30 | $538 |
| 2016-06-30 | $557 |
| 2016-03-31 | $517 |
| 2015-12-31 | $495 |
| 2015-09-30 | $469 |
| 2015-06-30 | $458 |
| 2015-03-31 | $454 |
| 2014-12-31 | $458 |
| 2014-09-30 | $439 |
| 2014-06-30 | $424 |
| 2014-03-31 | $377 |
| 2013-12-31 | $392 |
| 2013-09-30 | $367 |
| 2013-06-30 | $394 |
| 2013-03-31 | $376 |
| 2012-12-31 | $388 |
| 2012-09-30 | $336 |
| 2012-06-30 | $352 |
| 2012-03-31 | $332 |
| 2011-12-31 | $311 |
| 2011-09-30 | $287 |
| 2011-06-30 | $303 |
| 2011-03-31 | $288 |
| 2010-12-31 | $279 |
| 2010-09-30 | $253 |
| 2010-06-30 | $265 |
| 2010-03-31 | $242 |
| 2009-12-31 | $245 |
| 2009-09-30 | $227 |
| 2009-06-30 | $234 |
| 2009-03-31 | $217 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.599B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.706B | 24.73 |
| Intuitive Surgical (ISRG) | United States | $193.352B | 101.09 |
| Alcon (ALC) | Switzerland | $43.519B | 29.12 |
| IQVIA Holdings (IQV) | United States | $36.625B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $35.273B | 41.54 |
| DexCom (DXCM) | United States | $30.978B | 46.65 |
| Waters (WAT) | United States | $22.985B | 33.99 |
| STERIS (STE) | Ireland | $21.603B | 24.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.257B | 0.00 |
| Hologic (HOLX) | United States | $17.928B | 19.36 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.368B | 13.72 |
| Sysmex ADR (SSMXY) | Japan | $13.192B | 41.37 |
| Globus Medical (GMED) | United States | $11.424B | 28.93 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.192B | 44.48 |
| Teleflex (TFX) | United States | $9.024B | 14.39 |
| Glaukos (GKOS) | United States | $7.669B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.015B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.655B | 26.38 |
| Veracyte (VCYT) | United States | $3.419B | 102.61 |
| Inari Medical (NARI) | United States | $3.051B | 0.00 |
| TransMedics (TMDX) | United States | $2.857B | 90.57 |
| LivaNova (LIVN) | United Kingdom | $2.839B | 16.39 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.209B | 19.86 |
| Tandem Diabetes Care (TNDM) | United States | $2.135B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.848B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.284B | 0.00 |
| Artivion (AORT) | United States | $1.242B | 82.28 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.901B | 15.31 |
| Paragon 28 (FNA) | United States | $0.864B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.738B | 0.00 |
| IRadimed (IRMD) | United States | $0.682B | 36.87 |
| Mesa Laboratories (MLAB) | United States | $0.660B | 15.55 |
| AxoGen (AXGN) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.561B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.503B | 29.61 |
| Tactile Systems Technology (TCMD) | United States | $0.446B | 24.14 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.241B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.160B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.140B | 15.02 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.100B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |